These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 22640851)

  • 1. Pharmacologic agents for mucus clearance in bronchiectasis.
    Nair GB; Ilowite JS
    Clin Chest Med; 2012 Jun; 33(2):363-70. PubMed ID: 22640851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucoactive agents for chronic, non-cystic fibrosis lung disease: A systematic review and meta-analysis.
    Tarrant BJ; Le Maitre C; Romero L; Steward R; Button BM; Thompson BR; Holland AE
    Respirology; 2017 Aug; 22(6):1084-1092. PubMed ID: 28397992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expanding armamentarium of drugs to aid sputum clearance: how should they be used to optimize care?
    Bilton D; Stanford G
    Curr Opin Pulm Med; 2014 Nov; 20(6):601-6. PubMed ID: 25221855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial.
    Bilton D; Tino G; Barker AF; Chambers DC; De Soyza A; Dupont LJ; O'Dochartaigh C; van Haren EH; Vidal LO; Welte T; Fox HG; Wu J; Charlton B;
    Thorax; 2014 Dec; 69(12):1073-9. PubMed ID: 25246664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of inhaled dry powder mannitol on mucus and its clearance.
    Daviskas E; Rubin BK
    Expert Rev Respir Med; 2013 Feb; 7(1):65-75. PubMed ID: 23362816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effect of inhaled mannitol and cough in asthmatics with mucociliary dysfunction.
    Daviskas E; Anderson SD; Eberl S; Young IH
    Respir Med; 2010 Nov; 104(11):1645-53. PubMed ID: 20576419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhalation of dry powder mannitol improves clearance of mucus in patients with bronchiectasis.
    Daviskas E; Anderson SD; Eberl S; Chan HK; Bautovich G
    Am J Respir Crit Care Med; 1999 Jun; 159(6):1843-8. PubMed ID: 10351929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osmotic stimuli increase clearance of mucus in patients with mucociliary dysfunction.
    Daviskas E; Robinson M; Anderson SD; Bye PT
    J Aerosol Med; 2002; 15(3):331-41. PubMed ID: 12396422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy of impaired mucociliary clearance in non-CF pediatric lung disease. A review of the literature.
    Boogaard R; de Jongste JC; Merkus PJ
    Pediatr Pulmonol; 2007 Nov; 42(11):989-1001. PubMed ID: 17902149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled hyperosmolar agents for bronchiectasis.
    Wills P; Greenstone M
    Cochrane Database Syst Rev; 2006 Apr; (2):CD002996. PubMed ID: 16625566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled mannitol in cystic fibrosis.
    Wills PJ
    Expert Opin Investig Drugs; 2007 Jul; 16(7):1121-6. PubMed ID: 17594195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled mannitol in the treatment of non-cystic fibrosis bronchiectasis in adults.
    Gjoerup J; Hilberg O; Bendstrup E
    Respirology; 2012 Aug; 17(6):927-32. PubMed ID: 22564014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of pulmonary clearance medications in the acutely ill patient.
    Papacostas MF; Luckett P; Hupp S
    Expert Rev Respir Med; 2017 Oct; 11(10):815-826. PubMed ID: 28780895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled mannitol for the treatment of cystic fibrosis.
    Hurt K; Bilton D
    Expert Rev Respir Med; 2012 Feb; 6(1):19-26. PubMed ID: 22283575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of mannitol and repetitive coughing on the sputum properties in bronchiectasis.
    Daviskas E; Anderson SD; Young IH
    Respir Med; 2010 Mar; 104(3):371-7. PubMed ID: 19914814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis.
    Kellett F; Robert NM
    Respir Med; 2011 Dec; 105(12):1831-5. PubMed ID: 22018993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Airway clearance strategies in cystic fibrosis and non-cystic fibrosis bronchiectasis.
    Main E; Grillo L; Rand S
    Semin Respir Crit Care Med; 2015 Apr; 36(2):251-66. PubMed ID: 25826592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled mucoactive drugs for treating non-cystic fibrosis bronchiectasis in children.
    Snijders D; Calgaro S; Bertozzi I; Quartesan S; Kozuh I; Lunardi F; Barbato A
    Int J Immunopathol Pharmacol; 2013; 26(2):529-34. PubMed ID: 23755770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nebulized hypertonic saline in noncystic fibrosis bronchiectasis: a comprehensive review.
    Máiz Carro L; Martínez-García MA
    Ther Adv Respir Dis; 2019; 13():1753466619866102. PubMed ID: 31390940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled hyperosmolar agents for bronchiectasis.
    Wills P; Greenstone M
    Cochrane Database Syst Rev; 2001; (2):CD002996. PubMed ID: 11406058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.